J.P. Morgan Maintains MetLife(MET.US) With Buy Rating, Raises Target Price to $88

摩根大通維持大都會人壽(MET.US)買入評級，上調目標價至88美元

moomoo資訊 · 01/07 04:36 · 評級/大行評級

J.P. Morgan analyst Jimmy Bhullar maintains $MetLife (MET.US)$ with a buy rating, and adjusts the target price from $86 to $88.

According to TipRanks data, the analyst has a success rate of 57.7% and a total average return of 7.3% over the past year.

AnalystRecentRatingAutoNews_202978_20250107_cc50daec69b8a8941937652c4d3d8f9581fab61e_1736328616740583_mm_en

Furthermore, according to the comprehensive report, the opinions of $MetLife (MET.US)$'s main analysts recently are as follows:

The long-term fundamental outlook for the life insurance sector appears downbeat, yet there is a near-term bullish sentiment on stocks. Supported by a favorable macroeconomic backdrop, robust balance sheets, and the flexibility for share buybacks at current valuations, life insurance stocks are expected to continue to outperform. The primary risk to this optimistic view is a potential deterioration in corporate credit.
The optimism for life insurers remains robust due to forecasts of improving free cash flow, favorable impacts from rising interest rates, substantial excess capital, strong earnings from group benefits, and the potential for more reinsurance and merger activities. While property and casualty remain high-quality sectors over long periods, the current phase of the underwriting cycle makes property coverage more challenging. Additionally, trends in casualty loss costs present risks that may hinder more favorable developments. Thus, selectiveness in stock choices is emphasized.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

摩根大通分析師Jimmy Bhullar維持$大都會人壽 (MET.US)$買入評級，並將目標價從86美元上調至88美元。

根據TipRanks數據顯示，該分析師近一年總勝率為57.7%，總平均回報率為7.3%。

AnalystRecentRatingAutoNews_202978_20250107_cc50daec69b8a8941937652c4d3d8f9581fab61e_1736328616740583_mm_tc

此外，綜合報道，$大都會人壽 (MET.US)$近期主要分析師觀點如下：

人壽保險行業的長期基本面前景似乎悲觀，但短期內對股票的看漲情緒。在有利的宏觀經濟背景、強勁的資產負債表以及按當前估值進行股票回購的靈活性的支持下，人壽保險股預計將繼續跑贏大盤。這種樂觀觀點的主要風險是企業信貸的潛在惡化。
人壽保險公司的樂觀情緒仍然強勁，這要歸因於自由現金流將改善、利率上升的有利影響、大量過剩的資本、強勁的集團福利收益以及可能開展更多再保險和合並活動。儘管長期以來財產和意外傷害行業仍然是高質量的行業，但目前的承保週期階段使財產保險更具挑戰性。此外，傷亡損失成本的趨勢帶來風險，可能會阻礙更有利的發展。因此，強調了股票選擇的選擇性。

提示:

TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。

TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。

分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。

總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

J.P. Morgan Maintains MetLife(MET.US) With Buy Rating, Raises Target Price to $88

J.P. Morgan Maintains MetLife(MET.US) With Buy Rating, Raises Target Price to $88

風險及免責聲明

聲明